Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1994 | 12-1993 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,530 | N/A |
| Receivables | 90 | N/A |
| Inventories | 230 | N/A |
| Other current assets | 80 | 0 |
| TOTAL | $1,930 | $N/A |
| Non-Current Assets | ||
| Other Non-Current Assets | 170 | 0 |
| TOTAL | $170 | $N/A |
| Total Assets | $2,310 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 250 | 0 |
| Accrued Expenses | 160 | N/A |
| Other current liabilities | 510 | N/A |
| TOTAL | $950 | $N/A |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $950 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 140 | N/A |
| Retained earnings | -6,810 | N/A |
| TOTAL | $1,360 | $N/A |
| Total Liabilities And Equity | $2,310 | $0 |